Joseph A Church

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children
    Joseph A Church
    Department of Pediatrics, Children s Hospital Los Angeles and Keck School of Medicine, University of Southern California, 90027, USA
    Pediatr Infect Dis J 21:653-9. 2002
  2. ncbi Oxandrolone treatment of childhood hereditary angioedema
    Joseph A Church
    Division of Clinical Immunology and Allergy, Department of Pediatrics, Childrens Hospital Los Angeles and Keck of School of Medicine, The University of Southern California, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 92:377-8. 2004
  3. ncbi Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children
    Joseph A Church
    Childrens Hospital Los Angeles, Division of Clinical Immunology and Allergy, CA 90027, USA
    Pediatr Infect Dis J 23:713-8. 2004
  4. ncbi A pediatric genetic disorder diagnosed in adulthood
    Joseph A Church
    The Childrens Hospital, Keck School of Medicine, University of Southern California, Los Angeles, USA
    PLoS Med 3:e15. 2006
  5. ncbi Pectin anaphylaxis and possible association with cashew allergy
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 97:759-60. 2006
  6. ncbi Denial of insurance authorization at a subspecialty office as a cause of missed opportunities for influenza vaccination in children with asthma
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, 4650 Sunset Blvd, MS 75, Los Angeles, CA 90027, USA
    Arch Pediatr Adolesc Med 160:987-8. 2006
  7. ncbi Mixed-up nuts: identification of peanuts and tree nuts by children
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 97:73-7. 2006
  8. ncbi Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era
    Sharon A Nachman
    Department of Pediatrics, Stony Brook University Medical Center, Stony Brook, NY 11794 8111, USA
    Arch Pediatr Adolesc Med 163:164-71. 2009
  9. ncbi Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment
    Adriana Weinberg
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    J Acquir Immune Defic Syndr 52:17-24. 2009
  10. ncbi Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1
    Saro H Armenian
    Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA
    Pediatr Infect Dis J 25:368-70. 2006

Detail Information

Publications19

  1. ncbi Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children
    Joseph A Church
    Department of Pediatrics, Children s Hospital Los Angeles and Keck School of Medicine, University of Southern California, 90027, USA
    Pediatr Infect Dis J 21:653-9. 2002
    ..The fusion inhibitor T-20 is the first in this new class, and the present study is the first to examine chronic s.c. administration of T-20 to HIV-1-infected children...
  2. ncbi Oxandrolone treatment of childhood hereditary angioedema
    Joseph A Church
    Division of Clinical Immunology and Allergy, Department of Pediatrics, Childrens Hospital Los Angeles and Keck of School of Medicine, The University of Southern California, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 92:377-8. 2004
    ..Oxandrolone is a synthetic anabolic steroid with limited virilizing effects that has been used in a variety of pediatric conditions and has an acceptable safety profile...
  3. ncbi Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children
    Joseph A Church
    Childrens Hospital Los Angeles, Division of Clinical Immunology and Allergy, CA 90027, USA
    Pediatr Infect Dis J 23:713-8. 2004
    ..The safety and antiretroviral activity of enfuvirtide treatment of 24 weeks in HIV-1-infected children has been previously documented. Here we present the long term tolerability and safety of enfuvirtide...
  4. ncbi A pediatric genetic disorder diagnosed in adulthood
    Joseph A Church
    The Childrens Hospital, Keck School of Medicine, University of Southern California, Los Angeles, USA
    PLoS Med 3:e15. 2006
  5. ncbi Pectin anaphylaxis and possible association with cashew allergy
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 97:759-60. 2006
    ..Inhalation of pectin has been identified as a cause of occupational asthma. However, allergic reactions to orally ingested pectin have not been reported...
  6. ncbi Denial of insurance authorization at a subspecialty office as a cause of missed opportunities for influenza vaccination in children with asthma
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, 4650 Sunset Blvd, MS 75, Los Angeles, CA 90027, USA
    Arch Pediatr Adolesc Med 160:987-8. 2006
  7. ncbi Mixed-up nuts: identification of peanuts and tree nuts by children
    Ronald M Ferdman
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Ann Allergy Asthma Immunol 97:73-7. 2006
    ..Peanuts and tree nuts frequently cause severe allergic reactions. Nut avoidance is the key treatment, and accurate identification of nuts is essential for successful avoidance...
  8. ncbi Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era
    Sharon A Nachman
    Department of Pediatrics, Stony Brook University Medical Center, Stony Brook, NY 11794 8111, USA
    Arch Pediatr Adolesc Med 163:164-71. 2009
    ....
  9. ncbi Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment
    Adriana Weinberg
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    J Acquir Immune Defic Syndr 52:17-24. 2009
    ..We sought to identify the immunologic and virologic factors associated with a robust response to hepatitis A virus (HAV) vaccine in children on highly active antiretroviral treatment...
  10. ncbi Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1
    Saro H Armenian
    Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA
    Pediatr Infect Dis J 25:368-70. 2006
    ..The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination...
  11. ncbi Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells
    Greg M Podsakoff
    Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA 90027, USA
    Mol Ther 12:77-86. 2005
    ..These findings indicate that there was a selective survival advantage for PBMC containing the huM10 gene during the time of increased HIV-1 load...
  12. ncbi Association of staphylococcal superantigen-specific immunoglobulin e with mild and moderate atopic dermatitis
    Peck Y Ong
    Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    J Pediatr 153:803-6. 2008
    ..To examine the frequency of allergic sensitization to staphylococcal superantigens in young children with mild to moderate atopic dermatitis (AD)...
  13. ncbi Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles
    Thao Pham
    David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Clin Diagn Lab Immunol 10:323-8. 2003
    ..These data demonstrate the utility of TREC assessment in adolescents and that HIV infection does not uniformly result in accelerated thymic involution in childhood...
  14. ncbi Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy
    Jason C Lee
    David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1721, USA
    AIDS 20:667-74. 2006
    ..CONCLUSIONS: Long term survivors of pediatric HIV infection appear to have retained or recovered thymic volume and thymic activity approximating uninfected youths...
  15. ncbi Progressive outer retinal necrosis caused by varicella-zoster virus in children with acquired immunodeficiency syndrome
    Kenneth W Purdy
    Division of Infectious Diseases, Department of Pediatrics, Jules Stein Eye Institute, UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA
    Pediatr Infect Dis J 22:384-6. 2003
  16. ncbi Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationships
    Dolors Soy
    Department of Biopharmaceutical Sciences, School of Pharmacy, University of California-San Francisco, San Francisco, Calif, USA
    Clin Pharmacol Ther 74:569-80. 2003
    ..CONCLUSIONS: Regarding pharmacokinetics and pharmacodynamics, no statistically significant correlation between exposure measures and viral clearance was observed...
  17. ncbi Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study
    Paige L Williams
    Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA 02115 6017, USA
    Am J Epidemiol 167:1375-86. 2008
    ..Although participant characteristics are difficult to modify, the authors identified several potentially modifiable site practices that could be targeted to improve retention...
  18. ncbi Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)
    William T Shearer
    J Allergy Clin Immunol 118:518-21. 2006
  19. ncbi Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children
    Courtney V Fletcher
    J Allergy Clin Immunol 119:747-50. 2007